MedPath

Larfen

Brand Name: Larfen

Generic Name: Raloxifene Hydrochloride

Active
Registration Number

DR-XY43329

Dosage Form

Film Coated Tablet

Issuance Date

November 23, 2023

Expiry Date

April 1, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength60 mg
PackagingTransparent PVC/PE/PVDC Aluminum Foil Blister Pack x 7's (Box of 28's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Selective Estrogen Receptor Modulator
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Raloxifene HydrochlorideActive
Monograph: Raloxifene

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.